28 /100
MEDIUM RISK
Score updated Jul 14, 2026

IKT — Inhibikase Therapeutics, Inc. Dilution Risk Tracker

Track IKT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IKT — Get alerts when the score changes →

As of July 14, 2026, Inhibikase Therapeutics, Inc. (IKT) has a DilutionWatch DilutionScore of 28/100, rated MEDIUM dilution risk. Inhibikase Therapeutics, Inc. has a market capitalization of $231.06M, 132.03M shares outstanding, 104 institutional holders tracked. Key dilution vectors include 1.94M outstanding warrants, approximately 138 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.79 approaching $1 threshold
🔔 Track IKT — Get forecast alerts →

💹 Market Data

Market Cap$231.06M
Shares Outstanding132.03M
Float86.88M
Cash$299.60M
Debt$381.8K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 9.6% shares (2026Q1 vs prior)
104 institutional holders · 125.60M shares
#1 Sands Capital Alternatives, LLC 13.02M shares
#2 Soleus Capital Management, L.P. 10.88M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 8.90M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest19.42M
Days to Cover17.4
% of Float22.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 28, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for IKT Shareholders

Inhibikase Therapeutics, Inc. (IKT) has a DilutionScore of 28/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch tracks 1.9M outstanding warrants for IKT. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for IKT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for IKT alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track IKT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IKT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for IKT
📊 IKT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 IKT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.